167 related articles for article (PubMed ID: 30689868)
41. Characterization of neuromuscular synapse function abnormalities in multiple Duchenne muscular dystrophy mouse models.
van der Pijl EM; van Putten M; Niks EH; Verschuuren JJ; Aartsma-Rus A; Plomp JJ
Eur J Neurosci; 2016 Jun; 43(12):1623-35. PubMed ID: 27037492
[TBL] [Abstract][Full Text] [Related]
42. Haploinsufficiency of utrophin gene worsens skeletal muscle inflammation and fibrosis in mdx mice.
Zhou L; Rafael-Fortney JA; Huang P; Zhao XS; Cheng G; Zhou X; Kaminski HJ; Liu L; Ransohoff RM
J Neurol Sci; 2008 Jan; 264(1-2):106-11. PubMed ID: 17889902
[TBL] [Abstract][Full Text] [Related]
43. RhoA mediates defective stem cell function and heterotopic ossification in dystrophic muscle of mice.
Mu X; Usas A; Tang Y; Lu A; Wang B; Weiss K; Huard J
FASEB J; 2013 Sep; 27(9):3619-31. PubMed ID: 23704088
[TBL] [Abstract][Full Text] [Related]
44. NF-kappaB p50 and p52 expression is not required for RANK-expressing osteoclast progenitor formation but is essential for RANK- and cytokine-mediated osteoclastogenesis.
Xing L; Bushnell TP; Carlson L; Tai Z; Tondravi M; Siebenlist U; Young F; Boyce BF
J Bone Miner Res; 2002 Jul; 17(7):1200-10. PubMed ID: 12096833
[TBL] [Abstract][Full Text] [Related]
45. Utrophin A is essential in mediating the functional adaptations of mdx mouse muscle following chronic AMPK activation.
Al-Rewashdy H; Ljubicic V; Lin W; Renaud JM; Jasmin BJ
Hum Mol Genet; 2015 Mar; 24(5):1243-55. PubMed ID: 25324540
[TBL] [Abstract][Full Text] [Related]
46. Multipotential mesoangioblast stem cell therapy in the mdx/utrn-/- mouse model for Duchenne muscular dystrophy.
Berry SE; Liu J; Chaney EJ; Kaufman SJ
Regen Med; 2007 May; 2(3):275-88. PubMed ID: 17511564
[TBL] [Abstract][Full Text] [Related]
47. Correlation of Utrophin Levels with the Dystrophin Protein Complex and Muscle Fibre Regeneration in Duchenne and Becker Muscular Dystrophy Muscle Biopsies.
Janghra N; Morgan JE; Sewry CA; Wilson FX; Davies KE; Muntoni F; Tinsley J
PLoS One; 2016; 11(3):e0150818. PubMed ID: 26974331
[TBL] [Abstract][Full Text] [Related]
48. Alternative utrophin mRNAs contribute to phenotypic differences between dystrophin-deficient mice and Duchenne muscular dystrophy.
Perkins KJ; Davies KE
FEBS Lett; 2018 Jun; 592(11):1856-1869. PubMed ID: 29772070
[TBL] [Abstract][Full Text] [Related]
49. Decreased myocardial nNOS, increased iNOS and abnormal ECGs in mouse models of Duchenne muscular dystrophy.
Bia BL; Cassidy PJ; Young ME; Rafael JA; Leighton B; Davies KE; Radda GK; Clarke K
J Mol Cell Cardiol; 1999 Oct; 31(10):1857-62. PubMed ID: 10525423
[TBL] [Abstract][Full Text] [Related]
50. Protein-Anchoring Therapy of Biglycan for Mdx Mouse Model of Duchenne Muscular Dystrophy.
Ito M; Ehara Y; Li J; Inada K; Ohno K
Hum Gene Ther; 2017 May; 28(5):428-436. PubMed ID: 27485975
[TBL] [Abstract][Full Text] [Related]
51. Activation of calcineurin and stress activated protein kinase/p38-mitogen activated protein kinase in hearts of utrophin-dystrophin knockout mice.
Nakamura A; Harrod GV; Davies KE
Neuromuscul Disord; 2001 Apr; 11(3):251-9. PubMed ID: 11297940
[TBL] [Abstract][Full Text] [Related]
52. RhoA/ROCK inhibition improves the beneficial effects of glucocorticoid treatment in dystrophic muscle: implications for stem cell depletion.
Mu X; Tang Y; Takayama K; Chen W; Lu A; Wang B; Weiss K; Huard J
Hum Mol Genet; 2017 Aug; 26(15):2813-2824. PubMed ID: 28549178
[TBL] [Abstract][Full Text] [Related]
53. Impaired muscle spindle function in murine models of muscular dystrophy.
Gerwin L; Rossmanith S; Haupt C; Schultheiß J; Brinkmeier H; Bittner RE; Kröger S
J Physiol; 2020 Apr; 598(8):1591-1609. PubMed ID: 32003874
[TBL] [Abstract][Full Text] [Related]
54. Expression of either NF-kappaB p50 or p52 in osteoclast precursors is required for IL-1-induced bone resorption.
Xing L; Carlson L; Story B; Tai Z; Keng P; Siebenlist U; Boyce BF
J Bone Miner Res; 2003 Feb; 18(2):260-9. PubMed ID: 12568403
[TBL] [Abstract][Full Text] [Related]
55. Improved Bone Quality and Bone Healing of Dystrophic Mice by Parabiosis.
Li H; Lu A; Gao X; Tang Y; Ravuri S; Wang B; Huard J
Metabolites; 2021 Apr; 11(4):. PubMed ID: 33923553
[TBL] [Abstract][Full Text] [Related]
56. Utrophin suppresses low frequency oscillations and coupled gating of mechanosensitive ion channels in dystrophic skeletal muscle.
Lansman JB
Channels (Austin); 2015; 9(3):145-60. PubMed ID: 25941878
[TBL] [Abstract][Full Text] [Related]
57. Immunoglobulin therapy ameliorates the phenotype and increases lifespan in the severely affected dystrophin-utrophin double knockout mice.
Nunes BG; Loures FV; Bueno HMS; Cangussu EB; Goulart E; Coatti GC; Caldini EG; Condino-Neto A; Zatz M
Eur J Hum Genet; 2017 Dec; 25(12):1388-1396. PubMed ID: 29255177
[TBL] [Abstract][Full Text] [Related]
58. Identification of FHL1 as a therapeutic target for Duchenne muscular dystrophy.
D'Arcy CE; Feeney SJ; McLean CA; Gehrig SM; Lynch GS; Smith JE; Cowling BS; Mitchell CA; McGrath MJ
Hum Mol Genet; 2014 Feb; 23(3):618-36. PubMed ID: 24087791
[TBL] [Abstract][Full Text] [Related]
59. A-utrophin up-regulation in mdx skeletal muscle is independent of regeneration.
Weir AP; Morgan JE; Davies KE
Neuromuscul Disord; 2004 Jan; 14(1):19-23. PubMed ID: 14659408
[TBL] [Abstract][Full Text] [Related]
60. Enhanced expression of the alpha 7 beta 1 integrin reduces muscular dystrophy and restores viability in dystrophic mice.
Burkin DJ; Wallace GQ; Nicol KJ; Kaufman DJ; Kaufman SJ
J Cell Biol; 2001 Mar; 152(6):1207-18. PubMed ID: 11257121
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
